Cargando…
High Glucose Accelerates Tumor Progression by Regulating MEDAG-Mediated Autophagy Levels in Breast Cancer
Recent studies have shown that diabetes is a major risk factor for breast cancer (BC), but the mechanism is incompletely understood. Mesenteric estrogen-dependent adipogenesis (MEDAG) plays a significant role in both glucose uptake and BC development. However, the relationship between MEDAG and BC u...
Autores principales: | Li, Chenyuan, Sun, Si, Tu, Yi, Zhang, Hanpu, Yao, Feng, Liao, Shichong, Sun, Shengrong, Li, Zhiyu, Wang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295059/ https://www.ncbi.nlm.nih.gov/pubmed/35864962 http://dx.doi.org/10.7150/ijbs.70002 |
Ejemplares similares
-
MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway
por: Li, Zhiyu, et al.
Publicado: (2021) -
PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer
por: Zhang, Hanpu, et al.
Publicado: (2022) -
NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer
por: Li, Zhiyu, et al.
Publicado: (2021) -
Role of Escin in breast cancer therapy: potential mechanism for inducing ferroptosis and synergistic antitumor activity with cisplatin
por: Li, Chenyuan, et al.
Publicado: (2023) -
YAP/TAZ-mediated activation of serine metabolism and methylation regulation is critical for LKB1-deficient breast cancer progression
por: Wu, Qi, et al.
Publicado: (2017)